Submitted by Anonymous (not verified) on 11 November 2026 - 15:05
Human medicines European public assessment report (EPAR): Braftovi, encorafenib, Date of authorisation: 19/09/2018, Revision: 19, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Braftovi, encorafenib, Date of authorisation: 19/09/2018, Revision: 19, Status: Authorised